SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-099115
Filing Date
2024-04-17
Accepted
2024-04-17 16:17:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d643156ddefa14a.htm DEFA14A 11508
2 GRAPHIC g643156g02g02.jpg GRAPHIC 358594
3 GRAPHIC g643156g03g03.jpg GRAPHIC 68363
  Complete submission text file 0001193125-24-099115.txt   589724
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40656 | Film No.: 24851290
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)